A Potential New Target for Cancer Immunotherapies
New York, NY — Tumours can use an enzyme called ART1 to thwart antitumour immune cells, making the enzyme a promising new target for immunity-boosting cancer treatments, according to a study from researchers...
You must be logged in to post a comment.